New Key Statistics Module, Z-Score and F-Score
NAS:CLGN Key Ratios
| Market Cap $ M | 51.32 |
| Enterprise Value $ M | 39.20 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 13.29 |
| Price/Book | 3.03 |
| Price/Sales | 78.60 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -1.54 |
| Beneish M-Score | 4.95 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.99 |
| EV-to-EBITDA | -2.12 |
| PEG | -- |
| Shares Outstanding M | 11.45 |
| Net Margin (%) | -2,680.00 |
| Operating Margin % | -2,822.31 |
| Pre-tax Margin (%) | -2,680.00 |
| Quick Ratio | 5.23 |
| Current Ratio | 5.38 |
| ROA % (ttm) | -57.69 |
| ROE % (ttm) | -70.91 |
| ROIC % (ttm) | -259.34 |
| Dividend Yield % | -- |
| Altman Z-Score | -3.36 |
CLGN Number of Guru Trades
CLGN Volume of Guru Trades
Gurus Latest Trades with NAS:CLGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CLGN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CollPlant Biotechnologies Ltd Insider Transactions
No Available Data
News about NAS:CLGN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers